Genomics Collaborative, Inc. ("GCI") Company Profile

03:37 EST 16th December 2018 | BioPortfolio

Genomics Collaborative, Inc. ("GCI") was acquired by SeraCare LifeSciences in June of 2004.

GCI has developed expertise in applying the science of human genetics to drug and diagnostic discovery decisions. The Company's approach links human genes, proteins, and clinical outcomes through proprietary technology platforms. GCI's state-of-the-art technology offers a highly efficient method to validate genomics-based drug and diagnostic targets, and has already been validated through partnerships with more than 30 pharmaceutical and biotechnology companies. GCI believes that to broadly apply targets to drug or diagnostic development in the pharmaceutical market, they must be validated in human populations.

The Company provides a powerful combination of resources through its target validation program, GCI Access™. First, the program offers customized access to GCI's Global Repository™ of appropriately consented clinical research material. This includes human DNA, RNA, sera, and snap-frozen tissue samples linked to detailed medical information collected from patient populations worldwide. To date, the Company has recruited over 120,000 patients in building Global Repository™, and prospective collections continue in various disease states. Additionally, the GCI Access™ program offers customers expertise in proficiently designing and conducting human genetic studies geared towards the development of therapeutics and diagnostics.

Together with its study design, statistics, and analysis capabilities, GCI offers a suite of high throughput genomic analysis tools, including: SNP genotyping, DNA sequencing, RT-PCR, and gene expression analyses. These tools can be applied to leverage the assets of the Company's Global Repository™ in research settings. This combination places GCI at the forefront of the next generation of target validation and drug discovery.


99 Erie Street
United States of America


Phone: 617.661.2400
Fax: 617.661.8899

News Articles [561 Associated News Articles listed on BioPortfolio]

Vertex and Machine Learning Company Genomics Plc Enter Three Year Collaboration

Cystic fibrosis drugmaker Vertex Pharmaceuticals forged a three-year collaborative deal with U.K.-based machine learning specialist Genomics plc to improve the discovery of targets for precision medic...

M&As this week: 10x Genomics, Atlantic Research Group, AGC

10x Genomics has acquired Spatial Transcriptomics to enter the field of spatial genomics. The acquisition will enable 10x Genomics to gain...Read More... The post M&As this week: 10x Genomics, A...

Horizon Discovery Edit-R crRNA Libraries Adopted by AstraZeneca

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, announces that AstraZeneca has adopted its Edit-R™ crRNA libraries as part of AstraZeneca’s d...

10X Genomics Prepares to Hire 200 New Employees, Move into Larger Facility

Bay Area-based genomics company 10X Genomics has become one of the fastest growing privately-held companies in the region with an earnings increase of more than 2,000 percent over a three-year period.

TGen North partners with NARBHA Institute to promote human health

(The Translational Genomics Research Institute) Microbial pathogens -- the bacteria, viruses, fungi and parasites that can make you sick and even kill you -- often know no particular biological bounda...

Microsoft Genomics Ventures into the Microbiome With Eagle Genomics

LONDON, October 15, 2018 /PRNewswire/ -- Cambridge technology innovators partner with Microsoft Genomics Microbiomic research into immune disorders and antibiotic resistance First microbiome partn...

Festival of Genomics London 2018: the landmark event making genomics mainstream

London, UK, 5th January 2018 / Sciad Newswire / This January sees the third edition of Festival of Genomics London, the largest meeting of its kind in the UK. Following two US editions of the event ...

QUANTUM GENOMICS: Quantum Genomics receives ethics committee approval to initiate clinical study of extended-release firibastat tablets

Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), biopharmaceutical company specializing in the development of a new drug class that directly targets the brain to treat hypertension and h...

PubMed Articles [451 Associated PubMed Articles listed on BioPortfolio]

An empirical study of collaborative capacity evaluation and scheduling optimization for a CPD project.

In a collaborative product design project, reasonable resource allocation can shorten the development cycle and reduce cost. Team capacity evaluation and a task-team scheduling model are presented. A ...

Utilization of Genomics and Functional Genomics to Inform Clinical Decisions in IR.

The use of model constructs to design collaborative health information technologies: a case study to support child development.

Health information technology could provide valuable support for inter-professional collaboration to address complex health issues, but current HIT systems do not adequately support such collaboration...

Single-cell genomics.

An Examination of Screening Tools for Collaborative Care of Adolescent Depression.

Collaborative care models for treatment of adolescent depression are rapidly evolving. However, a dearth of information exists regarding patient characteristics associated with positive outcomes. We e...

Clinical Trials [455 Associated Clinical Trials listed on BioPortfolio]

Collaborative Care Intervention

The aims of the present study will be to pilot test the efficacy of a collaborative care intervention in patients treated with dialysis to reduce symptoms of depression, pain, sleep, fatig...

Evaluation of the Medical Psychiatry Alliance Senior's Outpatient Collaborative Care Project

This study evaluates the effectiveness of a collaborative care model designed to treat frail seniors with both a mental (anxiety and/or depression) and a physical health condition impactin...

Collaborative Care for Infants at Risk

This study evaluates the feasibility, acceptability, and impact of a collaborative care practice for infants investigated by state Child Protective Services (CPS) for suspected maltreatmen...

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older

The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...

Companies [768 Associated Companies listed on BioPortfolio]

Genomics Collaborative Incorporated

Genomics Collaborative, Inc's mission is to facilitate the discovery of genes associated with common diseases and the identification of pharmaceutical targets. Genomics Collaborative, Inc. (GCI) has d...

Genomics in Business

In 2003 Keygene initiated the first edition of Genomics in Business. It was the first conference to focus on the existing and future applications of genomics in the Agro-Food industry. With participan...

Genomics One Corporation

Genomics One is a fully integrated biotechnology company committed to the creation of shareholder value through innovation in the fields of genomics, proteomics and mono-clonal antibodies. The mission...

Center for Genomics and Bioinformatics

Center for Genomics and Bioinformatics The Center for Genomics and Bioinformatics (CGB) was launched in 1997 as a new academic department at the Karolinska Institute. Since then, the department has be...

Front Line Genomics

At Front Line Genomics our mission is to help deliver the benefits of genomics faster. Through our website, our magazine and the Festivals of Genomics, we support scientists, clin...

More Information about "Genomics Collaborative, Inc. ("GCI")" on BioPortfolio

We have published hundreds of Genomics Collaborative, Inc. ("GCI") news stories on BioPortfolio along with dozens of Genomics Collaborative, Inc. ("GCI") Clinical Trials and PubMed Articles about Genomics Collaborative, Inc. ("GCI") for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genomics Collaborative, Inc. ("GCI") Companies in our database. You can also find out about relevant Genomics Collaborative, Inc. ("GCI") Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Corporate Database Quicklinks

Searches Linking to this Company Record